J Korean Med Sci.  2007 Feb;22(1):7-11. 10.3346/jkms.2007.22.1.7.

Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration

• Yeom CH
• Jung GC
• Song KJ

• KMID: 1713221
• DOI: http://doi.org/10.3346/jkms.2007.22.1.7

Abstract

Over the years there has been a great deal of controversy on the effect of vitamin C on cancer. To investigate the effects of vitamin C on cancer patients' health-related quality of life, we prospectively studied 39 terminal cancer patients. All patients were given an intravenous administration of 10 g vitamin C twice with a 3-day interval and an oral intake of 4 g vitamin C daily for a week. And then we investigated demographic data and assessed changes in patients' quality of life after administration of vitamin C. Quality of life was assessed with EORTC QLQ-C30. In the global health/quality of life scale, health score improved from 36+/-18 to 55+/-16 after administration of vitamin C (p=0.001). In functional scale, the patients reported significantly higher scores for physical, role, emotional, and cognitive function after administration of vitamin C (p<0.05). In symptom scale, the patients reported significantly lower scores for fatigue, nausea/vomiting, pain, and appetite loss after administration of vitamin C (p<0.005). The other function and symptom scales were not significantly changed after administration of vitamin C. In terminal cancer patients, the quality of life is as important as cure. Although there is still controversy regarding anticancer effects of vitamin C, the use of vitamin C is considered a safe and effective therapy to improve the quality of life of terminal cancer patients.

Keyword

Neoplasms; Cancer; Ascorbic Acid; Quality of Life; Terminal Care

MeSH Terms

Terminal Care
*Quality of Life
Neoplasms/psychology
Middle Aged
Male
Humans
Female
Ascorbic Acid/*administration & dosage
Aged
Adult

Reference

1. Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003. 22:18–35.

2. Tamayo C, Richardson MA. Vitamin C as a cancer treatment: state of the science and recommendation for research. Altern Ther Health Med. 2003. 9:94–101.

3. Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Roman-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integrative Cancer Therapies. 2005. 4:32–44.

4. Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: a review. Cancer Res. 1979. 39:663–681.

5. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985. 312:137–141.

6. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004. 140:533–537.

7. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med. 1986. 314:892–902.

8. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Ann N Y Acad Sci. 1992. 669:7–20.

9. Leibovitz B, Mueller J. Carnitine. J Optimal Nutr. 1993. 2:90–109.

10. Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr. 1991. 53:270S–282S.

11. Komarova SV, Ataullakhanov FI, Globus RK. Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol. 2000. 279:C1220–C1229.

12. Khanzode SS, Muddeshwar MG, Khanzode SD, Dakhale GN. Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic Res. 2004. 38:81–85.

13. Lee JG, Chung HW, Lee KH, Ahn HS. Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J Korean Med Sci. 2005. 20:267–272.

14. Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004. 13:863–868.

15. Agus DB, Vera JC, Golde DW. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C. Cancer Res. 1999. 59:4555–4558.

16. Langemann H, Torhorst J, Kabiersch A, Krenger W, Honegger CC. Quantitive determination of water and lipid soluble antioxidants in neoplastic and non-neoplastic human breast tissue. Int J Cancer. 1989. 43:1169–1173.

17. Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer. 2001. 84:1544–1550.

18. Henson DE, Block G, Levine M. Ascorbic acid: biologic functions and relation to cancer. J Natl Cancer Inst. 1991. 83:547–550.

19. Do MH, Lee SS, Jung PJ, Lee HY. Intake of dietary fat and vitamin in relation to breast cancer risk in Korean women: a case-control study. J Korean Med Sci. 2003. 18:534–540.

20. Cameron E, Pauling L. Vitamin C and the immune system. Cancer and vitamin C. 1990. 2nd ed. USA: Camino Book;108–111.

21. Basu TK. Hanck A, Ritzel G, editors. Possible role of vitamin C in cancer therapy. Vitamin C: Recent Advances and aspects in virus disease, Cancer and in lipid metabolism. 1979. Hans Huber;95–102.

22. Tsao CS, Miyashita K. Effects of high intake of ascorbic acid on plasma levels of amino acids. IRCS Med Sci. 1984. 12:1052–1053.

23. Tsao CS, Miyashita K. Effects of large intake of ascorbic acid on urinary excretion of amino acids and related compounds. IRCS Med Sci. 1985. 13:855–856.

24. Lewin S. The link between ascorbate and c-AMP and c-GMP. Vitamin C: Its molecular biology and medical potential. 1976. London: Academic Press;93–98.

25. Lewin S. Activity of ascorbate in the adrenals. Vitamin C: Its molecular biology and medical potential. 1976. London: Academic Press;98–101.

26. Jensen NH. Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate. Ugeskr Laeger. 2003. 165:2563–2566.

27. Lewin S. Maintenance of physiological actions by c-AMP and c-GMP. Vitamin C: Its molecular biology and medical potential. 1976. London: Academic Press;92–93.

28. Luo G, Xie ZZ, Liu FY, Zhang GB. Effect of vitamin C on mitochondrial function and ATP content in hypoxic rats. Zhongguo Yao Li Xue Bao. 1998. 19:351–355.

29. Rivers JM. Safety of high-level vitamin C ingestion. In: Third conference on AA. Ann NY Acad Sci. 1987. 498:445–454.